Navigation Links
Hologic Announces Two-For-One Stock Split

(Subject to an Increase of Authorized Shares at the Annual Meeting of

Stockholders on March 11, 2008)

BEDFORD, Mass., Jan. 30 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX), a diversified medical technologies company specializing in diagnostics imaging systems and interventional devices dedicated to serving the healthcare needs of women, today announced that its Board of Directors has approved a two-for-one stock split, to be effected in the form of a stock dividend, subject to stockholder approval of a proposed amendment to the Certificate of Incorporation of the Company to increase the number of shares of Common Stock the Company has the authority to issue from 300 million to 750 million shares.

The Company is seeking approval of the amendment to its Certificate of Incorporation to increase the number of authorized shares of Common Stock at its Annual Meeting of Stockholders to be held on March 11, 2008. Subject to receiving such stockholder approval, the record date for the stock split will be March 21, 2008 and the payment date will be April 2, 2008. On the payment date, it is expected that the transfer agent will mail certificates representing one additional share for each share held on March 21, 2008 (or otherwise record the ownership of these additional shares). Should stockholder approval be obtained, the stock split will increase the number of shares of Common Stock outstanding from approximately 127.7 million to approximately 255.4 million shares. In addition, the Company has up to 28.3 million shares reserved for issuance under its 2.0% Convertible Notes due 2037, which will increase to 56.6 million after the stock dividend/split and additional shares reserved for issuance under its equity incentive plans. If such approval is not obtained, no dividend will be issued.

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, osteoporosis assessment, preterm birth risk assessment, and mini C-arm for extremity imaging. For more information visit

Forward Looking Disclaimer

This News Release contains forward-looking information that involves risks and uncertainties, including statements about the approval of the amendment to Hologic's Certificate of Incorporation at the annual meeting of stockholders and the payment of the stock dividend. These forward-looking statements are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those anticipated. Actual results could differ materially from Hologic's current expectations as a result of numerous factors, including the risk that the stockholders do not approve the amendment to Hologic's Certificate of Incorporation, in which case the stock dividend would not be paid. Other factors that could adversely affect Hologic's business and prospects are described in Hologic's filings with the Securities and Exchange Commission. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Hologic's expectations or any change in events, conditions or circumstances on which any such statement is based.

Additional Information and Where to Find It

In connection with the proposed amendment to Hologic's Certificate of Incorporation, Hologic has filed a proxy statement with the Securities and Exchange Commission. Investors and security holders are advised to read such proxy statement because it contains important information. Information regarding the interests of the participants in the solicitation of proxies is described in the proxy statement. Investors and other security holders can obtain copies of the proxy statement free of charge by directing a request to Hologic, Inc., 35 Crosby Drive, Bedford, MA 01730, Telephone (781) 999-7300. You may also obtain free copies of the proxy statement by accessing the SEC's website at

Contacts: Glenn P. Muir

Executive Vice President & CFO

Hologic, Inc.


Frances Doria

Director, Investor Relations

Hologic, Inc.


SOURCE Hologic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Does Pathological Shyness Make for School Shooters?
2. U of M study: Health food supplement may curb addiction of pathological gamblers
3. Hologic Sets Special Meeting of Stockholders to Vote on Proposed Merger with Cytyc Corporation
4. Hologic to Present at the UBS Global Life Sciences Conference
5. Hologic Acquires Biolucent, Inc.
6. Hologic Chairman and CEO to Open NASDAQ Stock Market on October 2, 2007
7. ISS Recommends Hologic Stockholders Vote FOR Merger With Cytyc
8. 1 in 5 bariatric surgery candidates not psychologically cleared for surgery
9. Hologic Stockholders Approve Merger with Cytyc
10. Exercise and psychological counseling could ease cancer-related fatigue
11. Cancer care providers need to proactively address patients psychological and social needs
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... CBD College is proud to ... Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. CBD College is honored ... one of twelve colleges and universities in the state of California make the cut. ...
(Date:11/26/2015)... ... November 26, 2015 , ... Patients at ... Michigan, have come together on Thanksgiving Day to share the things that they ... on the Serenity Point YouTube channel, patients displayed what they wrote on index ...
(Date:11/26/2015)... ... 26, 2015 , ... Jobs in hospital medical laboratories and in the imaging ... staffing agency Aureus Medical Group . These fields, as well as ... searching for healthcare jobs through the company’s website, , The leading ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor of the world-class ... improve system efficiency and reliability. , The new Q-Suite 6 platform is based on ... avoids locking itself into a specific piece of software for many key components of ...
(Date:11/25/2015)... ... November 25, 2015 , ... Medical Solutions, one of the ... stellar workplace culture with the company’s Cincinnati office being named a finalist among ... was named a finalist in Cincinnati Business Courier’s 13th annual Greater Cincinnati Best ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda ... magnetresonansbilder (MR-bilder) för patienter med multipel ... ett forskningsavtal med SyntheticMR AB för att ... forskningsprojekt på sjukhuset. Med SyMRI kan man ...
(Date:11/26/2015)... November 26, 2015 ... adds "Global Repaglinide Industry ... Report on China Repaglinide Market, 2010-2019" ... data and information to its online ... . --> ...
(Date:11/26/2015)... , November 26, 2015 ... of the "Radioimmunoassay Market by Type ... Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application ... Forecast to 2020" report to their ... announced the addition of the "Radioimmunoassay ...
Breaking Medicine Technology: